Literature DB >> 17364836

The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?

Shane Darke1, Joanne Ross, Maree Teesson.   

Abstract

Opioids make the single largest contribution to illicit drug-related mortality and morbidity worldwide In this paper we reflect upon what has been learnt regarding treatment outcome and the natural history of heroin use from the Australian Treatment Outcome Study (ATOS). We focus on what we knew prior to ATOS, what ATOS revealed that is novel, and the implications for research, practice and policy. ATOS provided strong evidence for sustained improvement attributable to treatment across the three years of the study. It is argued that treatment for heroin dependence is money well spent, and leads to clear and sustained benefits to both heroin users and society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364836     DOI: 10.1080/09595230601036986

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  17 in total

Review 1.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

2.  Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Margaret L Griffin; Scott E Provost; Garrett M Fitzmaurice; Katherine A McDermott; Emily N Srisarajivakul; Dorian R Dodd; Jessica A Dreifuss; R Kathryn McHugh; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2015-03-06       Impact factor: 4.492

3.  Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China.

Authors:  Mei Yang; Yanhui Liao; Qiang Wang; Marek C Chawarski; Wei Hao
Journal:  Drug Alcohol Depend       Date:  2015-02-02       Impact factor: 4.492

4.  Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence.

Authors:  Christine E Grella; Katherine Lovinger
Journal:  Addict Behav       Date:  2011-11-26       Impact factor: 3.913

5.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

6.  Consumer satisfaction with opioid treatment services at community pharmacies in Australia.

Authors:  Toby Lea; Janie Sheridan; Adam Winstock
Journal:  Pharm World Sci       Date:  2008-10-11

7.  Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs.

Authors:  Alexander Caudarella; Huiru Dong; M J Milloy; Thomas Kerr; Evan Wood; Kanna Hayashi
Journal:  Drug Alcohol Depend       Date:  2016-02-26       Impact factor: 4.492

8.  The Relationship of Alcohol and Other Drug Use Typologies to Sex Risk Behaviors among Vulnerable Women in Cape Town, South Africa.

Authors:  Wendee M Wechsberg; Bronwyn Myers; Tracy L Kline; Tara Carney; Felicia A Browne; Scott P Novak
Journal:  J AIDS Clin Res       Date:  2012-07-20

9.  Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users.

Authors:  Christy K Scott; Michael L Dennis
Journal:  Addiction       Date:  2009-03-13       Impact factor: 6.526

10.  Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006.

Authors:  Behnam Sharif; Bohdan Nosyk; Huiying Sun; David C Marsh; Aslam Anis
Journal:  Subst Use Misuse       Date:  2013-06-10       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.